IRIS
CAMELA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.128
NA - Nord America 1.777
EU - Europa 1.377
SA - Sud America 236
AF - Africa 72
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 5.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.728
SG - Singapore 907
RU - Federazione Russa 758
VN - Vietnam 372
CN - Cina 371
HK - Hong Kong 221
BR - Brasile 195
DE - Germania 159
IT - Italia 134
FR - Francia 100
IN - India 82
NL - Olanda 50
GB - Regno Unito 42
KR - Corea 37
JP - Giappone 31
UA - Ucraina 28
CI - Costa d'Avorio 24
CA - Canada 21
FI - Finlandia 21
ZA - Sudafrica 18
MX - Messico 15
PL - Polonia 14
BD - Bangladesh 13
SE - Svezia 13
PH - Filippine 12
TR - Turchia 11
AR - Argentina 10
BG - Bulgaria 10
IE - Irlanda 10
IQ - Iraq 10
ES - Italia 9
EC - Ecuador 8
ID - Indonesia 8
TH - Thailandia 8
VE - Venezuela 8
PK - Pakistan 6
UY - Uruguay 6
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
RS - Serbia 5
ET - Etiopia 4
LB - Libano 4
PE - Perù 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
EG - Egitto 3
RO - Romania 3
SN - Senegal 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
CG - Congo 2
CH - Svizzera 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SD - Sudan 1
SI - Slovenia 1
Totale 5.591
Salva come PNG Salva come JPEG
Città #
Singapore 412
San Jose 335
Ashburn 249
Hong Kong 211
Moscow 177
Chandler 150
Hefei 126
Ho Chi Minh City 116
Beijing 113
Santa Clara 97
Hanoi 83
Lauterbourg 50
Los Angeles 47
Amsterdam 37
The Dalles 33
Lawrence 32
Napoli 31
Millbury 26
Tokyo 26
Seoul 25
Seattle 24
São Paulo 23
Boston 22
Munich 22
Naples 21
Buffalo 20
Düsseldorf 20
New York 19
Redondo Beach 19
Wilmington 19
Kochi 18
Des Moines 17
Washington 17
Dallas 16
Menlo Park 15
Frankfurt am Main 14
Helsinki 13
Houston 13
Da Nang 12
Fairfield 12
Haiphong 12
Krefeld 12
Johannesburg 11
Warsaw 11
Council Bluffs 10
Milan 10
Brooklyn 9
Montreal 9
Orem 9
Pune 9
Sofia 9
Woodbridge 9
Can Tho 8
Phoenix 8
Rio de Janeiro 8
Atlanta 7
Chennai 7
Chicago 7
Hải Dương 7
Ankara 6
Nuremberg 6
San Francisco 6
Amman 5
Bhubaneswar 5
Brasília 5
Falkenstein 5
Mexico City 5
Montevideo 5
Querétaro 5
Thái Bình 5
Belo Horizonte 4
Biên Hòa 4
Bắc Giang 4
Bến Tre 4
Campinas 4
Fremont 4
Guangzhou 4
Kronberg 4
Lappeenranta 4
Poplar 4
Portsmouth 4
Redwood City 4
Shanghai 4
Stockholm 4
Turku 4
Afragola 3
Baghdad 3
Baku 3
Bucharest 3
Calgary 3
Columbus 3
Dakar 3
Denver 3
Dublin 3
Esslingen am Neckar 3
Gangnam-gu 3
Guarulhos 3
Hyderabad 3
Jakarta 3
Lima 3
Totale 3.067
Salva come PNG Salva come JPEG
Nome #
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case 175
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 174
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 171
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 170
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 163
A new dermoscopic pattern for chilblain-COVID-19–like skin lesions in adolescents 142
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 140
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 140
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 130
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 128
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 127
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 125
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 125
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 124
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 124
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 123
Nail changes as manifestation of systemic disease in COVID‐19 infection 123
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 122
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 118
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 116
Teledermatology: a useful tool also after Covid-19 era? 116
Risankizumab treatment in psoriasis patients who failed anti-IL17: a 52-week real-life study 115
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 114
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study 114
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 113
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 110
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5" 109
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 107
Letter to the editor regarding article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610." 107
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics 106
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis? 104
A case of pediatric psoriasis successfully and rapidly treated with ixekizumab 103
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al 102
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 102
A case of erythrodermic psoriasis successfully treated with guselkumab 98
A case of erythrodermic psoriasis successfully treated with apremilast 98
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 94
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 91
Reply to ‘New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination’ by Merhy et al 88
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting 83
Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al 77
New frontiers in personalized medicine in psoriasis 76
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 73
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge 71
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 70
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study 69
Giant basal cell carcinoma of the vulva successfully treated with Sonidegib 59
Towards Personalized Medicine in Psoriasis: Current Progress 57
Treating psoriasis in the elderly: biologics and small molecules 57
A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings 56
Reply to "Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: a single-center retrospective cohort study" 56
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 49
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 48
Paradoxical reactions to biologicals for psoriasis 46
Totale 5.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 8 8 0
2021/2022277 1 7 0 14 15 6 8 17 63 41 24 81
2022/2023454 37 35 15 17 39 56 49 64 65 36 32 9
2023/2024397 24 46 33 40 38 88 6 51 2 8 48 13
2024/20251.699 74 24 7 14 52 108 153 93 141 259 636 138
2025/20262.700 334 243 281 246 443 134 372 132 373 142 0 0
Totale 5.698